These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25515210)

  • 1. Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer's disease.
    Wells JA; Holmes HE; O'Callaghan JM; Colgan N; Ismail O; Fisher EM; Siow B; Murray TK; Schwarz AJ; O'Neill MJ; Collins EC; Lythgoe MF
    J Cereb Blood Flow Metab; 2015 Mar; 35(3):359-62. PubMed ID: 25515210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal assessment of cerebral perfusion and vascular response to hypoventilation in a bigenic mouse model of Alzheimer's disease with amyloid and tau pathology.
    Govaerts K; Lechat B; Struys T; Kremer A; Borghgraef P; Van Leuven F; Himmelreich U; Dresselaers T
    NMR Biomed; 2019 Feb; 32(2):e4037. PubMed ID: 30489666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510).
    Yang D; Xie Z; Stephenson D; Morton D; Hicks CD; Brown TM; Sriram R; O'Neill S; Raunig D; Bocan T
    Neuroimage; 2011 Feb; 54(4):2652-8. PubMed ID: 21035554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain metabolism in tau and amyloid mouse models of Alzheimer's disease: An MRI study.
    Wei Z; Xu J; Chen L; Hirschler L; Barbier EL; Li T; Wong PC; Lu H
    NMR Biomed; 2021 Sep; 34(9):e4568. PubMed ID: 34050996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease.
    Bennett RE; Robbins AB; Hu M; Cao X; Betensky RA; Clark T; Das S; Hyman BT
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1289-E1298. PubMed ID: 29358399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease.
    Hopp SC; Lin Y; Oakley D; Roe AD; DeVos SL; Hanlon D; Hyman BT
    J Neuroinflammation; 2018 Sep; 15(1):269. PubMed ID: 30227881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain.
    Kopeikina KJ; Carlson GA; Pitstick R; Ludvigson AE; Peters A; Luebke JI; Koffie RM; Frosch MP; Hyman BT; Spires-Jones TL
    Am J Pathol; 2011 Oct; 179(4):2071-82. PubMed ID: 21854751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial spin labeling demonstrates preserved regional cerebral blood flow in the P301L mouse model of tauopathy.
    Kindler D; Maschio C; Ni R; Zerbi V; Razansky D; Klohs J
    J Cereb Blood Flow Metab; 2022 Apr; 42(4):686-693. PubMed ID: 34822744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease.
    Ye C; Liang Y; Chen Y; Xiong Y; She Y; Zhong X; Chen H; Huang M
    Cells; 2021 May; 10(5):. PubMed ID: 34064687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology.
    Lee SH; Meilandt WJ; Xie L; Gandham VD; Ngu H; Barck KH; Rezzonico MG; Imperio J; Lalehzadeh G; Huntley MA; Stark KL; Foreman O; Carano RAD; Friedman BA; Sheng M; Easton A; Bohlen CJ; Hansen DV
    Neuron; 2021 Apr; 109(8):1283-1301.e6. PubMed ID: 33675684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.
    Shibuya Y; Niu Z; Bryleva EY; Harris BT; Murphy SR; Kheirollah A; Bowen ZD; Chang CCY; Chang TY
    Neurobiol Aging; 2015 Jul; 36(7):2248-2259. PubMed ID: 25930235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's disease.
    Wilcock DM; Gharkholonarehe N; Van Nostrand WE; Davis J; Vitek MP; Colton CA
    J Neurosci; 2009 Jun; 29(25):7957-65. PubMed ID: 19553436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligemic hypoperfusion differentially affects tau and amyloid-{beta}.
    Koike MA; Green KN; Blurton-Jones M; Laferla FM
    Am J Pathol; 2010 Jul; 177(1):300-10. PubMed ID: 20472896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2014 Mar; 20(1):29-36. PubMed ID: 24722782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.
    Scholtzova H; Chianchiano P; Pan J; Sun Y; Goñi F; Mehta PD; Wisniewski T
    Acta Neuropathol Commun; 2014 Sep; 2():101. PubMed ID: 25178404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy.
    Joly-Amado A; Hunter J; Quadri Z; Zamudio F; Rocha-Rangel PV; Chan D; Kesarwani A; Nash K; Lee DC; Morgan D; Gordon MN; Selenica MB
    Front Immunol; 2020; 11():997. PubMed ID: 32508844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study.
    Sahara N; Perez PD; Lin WL; Dickson DW; Ren Y; Zeng H; Lewis J; Febo M
    Neurobiol Aging; 2014 Jun; 35(6):1364-74. PubMed ID: 24411290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
    Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
    Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.